Publications by the researcher in collaboration with Eva Poveda López (21)

2022

  1. Author Correction: Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study (Scientific Reports, (2022), 12, 1, (3369), 10.1038/s41598-022-07414-x)

    Scientific Reports

2021

  1. Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study

    International Journal of Infectious Diseases, Vol. 102, pp. 45-52

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  3. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

  4. Seroprevalence of Hepatitis B, Hepatitis C, and human T-Cell lymphotropic virus infections in HIV-infected patients in Sierra Leone

    American Journal of Tropical Medicine and Hygiene, Vol. 100, Núm. 6, pp. 1521-1524

  5. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

    The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700

2017

  1. Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain

    AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017

  2. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2015

  1. Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak

    Infection, Genetics and Evolution, Vol. 30, pp. 96-101

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

    AIDS, Vol. 27, Núm. 14, pp. 2219-2224

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2011

  1. Variabilidad en la determinación del tropismo viral del VIH utilizando diferentes algoritmos genotípicos de interpretación en pacientes VIH-1 infectados con subtipos B versus no-B

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 1, pp. 4-8

2010

  1. Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 65, Núm. 12, pp. 2502-2504

2009

  1. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 5, pp. 1006-1010

2008

  1. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

    Journal of Clinical Microbiology, Vol. 46, Núm. 3, pp. 887-891

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182